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A B S T R A C T
The aim of this study was to evaluate the impact of risk factors for deep vein thrombosis (DVT) on thrombus sizes in
lower extremities. The size and extent of thrombus was scored according to International Consensus Committee for ve-
nous disease classification. After the diagnosis of DVT was established and its size scored, predominant risk factors for
DVT in each patient were identified (malignant disease, thrombophilia, postoperative state, hormonal therapy, hered-
ity, limb trauma, immobilization, others and unknown risk factors). The average thrombus score was 6 (95% CI 5.47–
6.53). The analysis of thrombus size indicated that the largest thrombi were found in patients with malignancy. Their
average score was 8.5 (95% CI 7–10) and was significantly higher than in patients with other risk factors for deep vein
thrombosis. There was no significant correlation between numbers of days from the onset of symptoms to the moment of
DVT diagnosis and thrombus score (r=–0.08, p=0.38). Age was very slightly correlated to thrombus size (r=0.19; p=0.046),
while the gender did not have significant impact on thrombus score (p=0.074). The conclusion of our study was that eti-
ology of thrombosis and particularly malignant diseases has the largest impact on venous thrombus size.
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Introduction
Deep vein thrombosis is an age-related disease for
which various risk factors are already identified: pro-
longed immobilization, cancer, thrombophilia, surgery,
heredity, pregnancy and estrogen use, nephrotic syn-
drome, indwelling intravenous catheters. After diagno-
sis of deep venous thrombosis is made by ultrasound, its
extent should be evaluated. Porter et Moneta on behalf
of International Consensus Committee for venous dis-
ease introduced anatomical distribution and scoring af-
ter which the thrombus load can be determined1. Its de-
termination is important because it may influence the
course of therapy and possibly is related to DVT com-
plications2. DVT may present in the whole spectrum of
severity ranging from small subsegmental partial clot
in posterior tibial veins to large multisegmental throm-
bi extending from illiac veins over femoral, popliteal to
crural veins. Small clots usually produce mild symp-
toms while large ones present with swelled and painful
leg3. Thrombus load and its relation to deep vein throm-
bosis complications was evaluated in many articles with
often controversial conclusions1,4–11. Meissner found that
popliteal location was more frequently associated with
the development of deep vein thrombosis than other
locations8. The extent of thrombosis was not evaluated
in literature with the risk factors for DVT, but spo-
radically1,10,12.
We hypothesized that various risk factors are associ-
ated with different thrombus score. Our intention was
to evaluate the role of individual risk factors in size and
location of DVT. Cancer causes hypercoaguable state
that may produce high thrombus load, particularly if
other risk factors such as surgery, indwelling catheters
and chemotherapy are present13–15.
Patients and Methods
Protocol
All patients with signs and symptoms suspected of
deep vein thrombosis referred for Doppler examination
from July 2003 to April 2004 entered the study. The pa-
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tients with ultrasonographically-confirmed first-time
deep vein thrombosis of pelvis or lower extremities were
included into the study.
Patient population
Hundred-twelve patients with diagnosed DVT were
enrolled into the study. There were 52 (46%) males and
60 (54%) females. The mean age of males was 60 years
(95% CI 55–64) and for females it was 61 years (95% CI
56–65, p=0.72).
Methods
Duplex examinations were performed in 15-degrees
reverse Trendelenburg position with Aloka 640, with 7.5
MHz transducer. All deep and superficial venous seg-
ments from the inferior vena cava to the crural veins
were imaged, and venous segments were classified as
patent, partially occluded or completely occluded on the
bases of standard ultrasound criteria which included
compressibility and the presence of spontaneous or aug-
mented Doppler and color flow2,16,17. Then, analysis of
involvement of an each venous segment according to In-
ternational Consensus Committee for venous disease
classification was performed1. Six venous segments
were taken for analysis: external illiac, common femo-
ral, superficial femoral, profound femoral, popliteal and
crural. For each segment a patient was assigned one
point which was multiplied with the level of occlusion.
The level of occlusion was scored as follows: 0 – patent
vein, 1 – subsegmental nonocclusive thrombus, 2 –
subsegmental occlusive thrombus, 3 – occlusive thrombus
throughout the entire segment. Patent vein was defined
by spontaneous biphasic flow and complete compress-
ibility of the vein. The criteria for complete occlusion
were absence of flow with distal compression and in-
compressibility of the vein. Nonocclusive thrombus was
defined by normal or diminished flow with distal com-
pression and partial incompressibility of the vein. The
final result was a thrombus score or load1. With this
scoring, the maximal number of points (thrombus score)
was 18.
Exclusion criteria
The number of days since symptoms of DVT started
to the time of diagnosis was recorded. The patients with
symptoms lasting longer than 2 weeks were excluded
from the study, because after that time, recanalization
by patients´ own fibrinolysis usually started. Also, the
patients with recurrent thrombosis were excluded, be-
cause we could not know the possible residual clot size.
In the »intention-to-treat« analysis there were 185 pa-
tients while per protocol analysis included 112 subjects.
Risk factors analysis
Careful search for risk factors for DVT was made.
The presence or absence of following risk factors for
DVT was recorded: malignant disease, immobilization >
3 days, earlier DVT, pregnancy, hormone replacement
therapy, smoking, obesity, varicose veins, family history
of DVT, recent surgery, recent trauma, and myocardial
infarction18. The incidence of risk factors is presented in
Figure 1. In patients with malignancy (diagnosed with-
in past 6 months), surgery, irradiation, chemotherapy
are termed as cancer-related procedures and treated as
one variable for statistical purposes. As the patients
were followed for their INR levels and thrombus resolu-
tion the detection of malignancy after DVT was re-
corded. As smoking, obesity, varicose veins, myocardial
infarction have only circumferential impact on DVT in-
cidence, they were analyzed together1,19. Patients youn-
ger than forty years were analyzed for thrombophilia.
The levels of antithrombin, protein C and S were mea-
sured20. Polymerase chain reaction for point mutation of
factor V (Leiden) and factor II were performed21. The
level of factor VIII was not determined because its true
role in pathogenesis of thrombosis is not yet completely
elucidated22. The assays on anticardiolipin antibodies
and lupus anticoagulants were also done14.
Statistical analysis
The data are presented as means and 95% confidence
intervals. As distribution was normal, parametric sta-
tistics was used. ANOVA was used to compare thrombus
load among various risk factors of thrombosis. Pearson
coefficient of correlation was used to estimate relation-
ship between thrombus score and number of days from
the onset of symptoms and the detection of DVT. The
level of significance was defined at 0.05, actual probabil-
ities were presented in the text. Statistical analysis was
performed with SPSS software (SPSS 11.5 Inc., Chicago,
Illinois).






































Fig. 1. Malignancy and thrombophilia were single most
frequent risk factors in 112 patients with DVT.
Results
Analysis of distribution of 251 occluded venous seg-
ments in 112 patients is presented in Figure 2. The most
common affected segments were superficial femoral (88;
35%) and popliteal vein (59; 23%). The distribution of
thrombus in each patient is presented in Table 1. Eighty-
-nine (79%) thrombi involved multiple anatomic seg-
ments and in 23 (21%) patients DVT was single-seg-
mental.
The most frequent thrombus site was femoropoliteal
(37/89; 42%), and ileofemoral (18/89; 20%). The average
thrombus load was 6 (95% CI 5.47–6.53) (Table 1).
Analysis for thrombophilia indicated 6 patients with
FV (Leiden) mutation, 2 patients with antiphospholipid
antibodies, 2 patients with F II G20210A, and 4 patients
with potentially serious thrombophilia (one with AT,
one with PC and 2 with PS deficiency, but the level of de-
ficiency was rather small in all four patients).
The patients were divided in 8 groups according to
predominant risk factor for DVT (Figure 3). Analysis of
variance (ANOVA – Tukey correction) has shown that
cancer patients had significantly higher thrombus load
than others (mean value 8.5; 95% CI 7–10) as shown in
Figure 3.
There were 24 patients with cancer (8 breast, 5 gas-
trointestinal, 3 genitourinary, 4 hematological and 4
miscellaneous malignancies). Most patients had com-
bined treatment: fourteen patients underwent surgery
for malignancy, 9 patients were on chemotherapy, and
10 patients on radiation therapy.
Pearson coefficient of correlation between thrombus
score and the time interval from onset of symptoms and
detection of thrombosis was – 0.08 (p=0.39). The major-
ity of DVT were diagnosed during the first week. It is
also obvious from Figure 4. that most DVT with high
thrombus score were detected early in the course of dis-
ease. Age was only slightly correlated to thrombus score
(r=0.19; p=0.046), while gender did not have significant
impact on thrombus score (p=0.074).





























Fig. 2. Anatomical distribution of affected venous segments by
deep vein thrombosis. The most common affected segments were
superficial femoral and popliteal vein.
TABLE 1
THE ANATOMIC DISTRIBUTION OF THROMBI SHOWING THE
NUMBER OF SINGLE AND MULTI-SEGMENTS INVOLVED










CFV +SFV + PFV 8
SFV + PV 37
SFV + PFV + PV + CV 4
PV+CV 5
ILV – illiac vein, CFV – common femoral vein, SFV – superfi-
cial femoral vein, PFV – profound femoral vein, PV – popliteal
vein, CV – crural veins
2810758161424N=






































Fig. 3. The means and 95% confidence intervals are presented
for risk factors for deep vein thrombosis. Malignancy had sig-
nificantly higher score than other risk factors.
Discussion
It is a challenge for any clinician to recognize a risk
for DVT, and to stratify patients according their risk
level to apply proper DVT prophylaxis. If DVT occurs, it is
important to recognize short-term and reversible risks
and avoid them in the future as well as lifelong risks
since they require different therapeutic approach13,23–25.
Beside risk factors, it is important to define the site and
extent of deep vein thrombosis, because these parame-
ters have predictive value in terms of possible thrombo-
sis recurrence or embolism as well as development of
postthrombotic syndrome9–12,26,27.
Our finding of predominant affection of superficial
femoral and popliteal segments is in accordance with
findings from other studies4,5,8,12.
Killewich et al in their study of thrombus load re-
gression by natural fibrinolytic activity found in 19 pa-
tients 33% segments affected and that is similar to our
results as they measured thrombus load in 5 segments.
Our initial thrombus load was different from theirs
5.79±2.68 vs. 4.5±0.6 partly due to their small number
of examined extremities and different classification. Be-
sides, they had only 3 patients with malignancy12.
Van Ramhorst analyzed 20 extremities with mean
thrombus load of 5. Out of 80 potential segments they
found 49 of them had intravascular occlusion. These re-
sults correspond to our findings but they did not refer to
risk factors for DVT at all10.
The study of Johnson about development of post-
thrombotic syndrome also found similar thrombus load,
the risk factors were presented but not associated with
thrombus load9.
Meissner et al in their study of determinants of
chronic venous disease after acute DVT followed 68 pa-
tients during 2 years. The initial thrombus load was
6.9±4.2. They found thrombosis of popliteal vein to be
associated with increased risk of postthrombotic syn-
drome. They also identified risk factors for DVT without
association with thrombus load8.
In another study about coagulation, fibrinolysis mar-
kers and recanalization Meissner et al found in 71 pa-
tients initial thrombus load to be 5.1±4.7. Risk factors
were analyzed but particular attention was paid to bio-
chemical markers and their temporal changes in rela-
tion to thrombus load5.
The common denominator of all these studies includ-
ing ours, are similar initial thrombus scores and distri-
bution of affected venous segments. The original contri-
bution of our study is an attempt to associate thrombus
load to risk factors for DVT.
In our study cancer was significantly better as pre-
dictor of thrombus load (mean value 8.5, 95% CI 7–10)
than other risk factors.
Cancer and its treatments are well-recognized risk
factors for venous thromboembolism (VTE). Evidence
suggests that the absolute risk depends on the tumor
type, the stage or extent of the cancer, and treatment
with antineoplastic agents. Furthermore, age, surgery,
immobilization, and other comorbid features will also
influence the overall likelihood of thrombotic complica-
tions, as they do in patients without cancer. The role of
hereditary thrombophilia in patients with cancer and
thrombosis is still unclear, and screening for this condi-
tion in cancer patients is not indicated. Patients under-
going surgery for cancer have a higher risk of postopera-
tive deep vein thrombosis (DVT) than those having
surgery for nonmalignant diseases13–15.
Cancer is a hypercoaguable state as reflected in in-
creased levels of coagulation parameters (D-dimer, pro-
thrombin fragment 1+2, thrombin-antithrombin and
plasmin-antiplasmin complexes). Surgery and chemo-
therapy were also contributing factors to thrombus load
and produce hypercoaguability of blood13–15. In this study
we did not present coagulation parameter levels, becau-
se they have low positive predictive value for thrombo-
sis2,11,28. Venous thrombus is a three-dimensional struc-
ture and it should be detected by imaging methods
rather than coagulation assays.
The patients with thrombophilia did not exhibit high
thrombus load. Analysis of particular types of throm-
bophilia has shown that there were only 4 patients with
serious defect (2 with antiphospholipid antibody syn-
drome and 2 with combined positive heterozygous mu-
tations for F V and F II) and this might explain rela-
tively low initial thrombus load29.
The lack of correlation between thrombus score and
time of detection of thrombosis is somewhat surprising as
there is a belief that thrombosis precipitates and in-
creases slowly as a function of time, producing symptoms
when venous outflow is obstructed2,28. Our results indi-
cate that in most cases large thrombus load is generated





































Fig. 4. There is no significant relationship between thrombus
load score and days from onset of symptoms to diagnosis of deep
vein thrombosis (r=–0.08, p=0.39).
during short period of time, while in other cases it precip-
itates slowly and increases in time. In latter case, the
pain in deep vein thrombosis is dull, unlike arterial
thrombosis where pain is sharp and incapacitating, and
patients affected do not ask medical examination.
The surgical patients had lower thrombus load probably
because of hospital stuff surveillance and awareness of pa-
tients of possible postsurgical DVT. Low-molecular-weight
heparins are used routinely as prophylaxis of DVT. In pa-
tients, where LMWH fail to prevent thrombosis their role
on reduction of thrombus size remains to be elucidated.
The limitation of the study is its cross-sectional char-
acter. Its shortcomings were partly avoided as we fol-
lowed all patients to keep INR levels within therapeutic
limits and were able to detect malignancy that was oc-
cult at the onset of thrombosis30. Visualization of throm-
bus score would have been probably better with veno-
graphy but its use to this purpose would be unethical. In
conclusion, our results indicate that further studies ex-
ploring the association between etiology of thrombosis
and thrombus score, particularly the rate of recana-
lization in various etiologies are necessary.
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VELI^INA TROMBA OVISI O ETIOLOGIJI DUBOKE VENSKE TROMBOZE
– PRESIJE^NA STUDIJA
S A @ E T A K
Cilj rada bio je procijeniti utjecaj rizi~nih faktora za nastanak duboke venske tromboze (DVT) donjih ekstremiteta
na veli~inu tromba. Veli~ina i pro{irenost tromboze je ocjenjena prema klasifikaciji Me|unarodnog kosenzus komi-
teta za bolesti vena. Nakon {to je kod 112 bolesnika potvr|ena DVT donjih ekstremiteta bojanim doplerom utvr|eni
su predominatni ~imbenici rizika koji su mogli dovesti do tromboze (maligna bolest, trombofilija, postoperativno sta-
nje, imobilizacija, hormonska terapija, nasljedna sklonost trombozi, trauma, ostali i nepoznati faktori). Prosje~na
veli~ina tromba je bila 6 (95% CI 5.47–6.53). Analizom veli~ine tromba utvr|eno je da su trombi najve}i kod bolesnika
sa malignim bolestima. Njihova prosje~na veli~ina iznosila je 8.5 (95% CI 7–10) i bila je statisti~ki zna~ajno ve}a nego
kod bolesnika sa drugim faktorima rizika za nastanak tromboze. Nije postojala zna~ajna korelacija izme|u broja
dana od po~etka pojave simptoma do detekcije tromboze (r=–0.08, p=0.39). Dob je pokazala niski stupanj korelacije sa
veli~inom tromba (r=0.19, p=0.046), dok spol nije imao utjecaja. Zaklju~ak na{e studije je da etiologija tromboze, a
posebno maligna bolest ima najve}i utjecaj na veli~inu tromba.
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